Navigenics is pleased to announce the appointment of a new company leader. Here are some details, as described in a news release:

Navigenics, a leading personal genomics testing company, announced today that Jonathan “Jack” T. Lord, M.D., has been appointed by the Board of Directors to serve as President and Chief Executive Officer of the firm.

Dr. Lord brings to Navigenics a history and passion for combining robust medical science with technological innovation to improve consumers’ health and access to quality care. Dr. Lord comes to Navigenics from Louisville, Kentucky-based Humana, Inc., where as Chief Innovation Officer he was responsible for designing new products and services to enable people to navigate the healthcare system and support their health needs.  Before Humana, Dr. Lord was president of Health Dialog in Boston, where he helped pioneer e-enabled health care. He has also served as chief operating officer of the American Hospital Association in Washington, D.C.  Previously, Dr. Lord was executive vice president of Anne Arundel Medical Center in Annapolis, MD, and executive vice president of Sun Health in Charlotte, NC.

“I am excited about the prospects of leading a company that will transform healthcare. Navigenics’ leadership in science, its exceptionally committed and leading edge investors, and strong management team make this the most exciting opportunity of my career,” said Dr. Lord.  “Passion for advancing personalized medicine defines Navigenics.  I am very honored to have the privilege to lead this company as we transform healthcare for the 21st century– an era of healthcare we hope will be marked by a focus on prediction and prevention.”

Read More

What’s a secret to possibly preventing heart disease, diabetes or Alzheimer’s disease?

There are many effective strategies for reducing your risk, ranging from getting regular exercise and watching your diet to avoiding cigarettes and controlling your cholesterol.

But another measure has been emerging as a prevention powerhouse, one that is rarely discussed – and still frequently overlooked – by many health-conscious individuals.

Read More

“This is not going to be your typical story about Alzheimer’s disease,” explained Nightline co-anchor Terry Moran. “…You get to come to my office and watch me spit in a tube.”

And so began Moran’s personal tale of his quest to discover whether Alzheimer’s disease might one day control his life, just as it had his mother’s not that many years ago.

By spitting into a special tube and shipping his saliva sample to Navigenics, Moran was able to experience first-hand one of the greatest breakthroughs in modern medicine – the ability to size up his genetic code and learn his personal genetic risk for a disease he has long abhorred.

“My moment of truth,” he told the cameras, as he prepared to get the results of his Navigenics genetic test. “I wanted to face my fears...”

Read More

It’s always nice to be recognized. Being called one of the “Fabulous Four” Bay Area businesses by a leading business columnist? Even better.

San Jose Mercury News writer Chris O’Brien recently featured Navigenics in his write-up of Bay Area companies that are succeeding during this global economic downturn. His profile is a pleasant acknowledgement of all the hard work that has gone into creating the genetic testing service that is most recommended by physicians. 

Read More

Just what is genetic testing and how can it help your health?

Tune into “The Doctors” show on television today and you’ll get answers.

The show’s “Secrets to Living Longer” episode – which will air at 4 p.m. on Fox in many media markets – features the Navigenics genetic testing services.

Learn how a simple saliva test can help you determine whether you are genetically predisposed to certain diseases such as colon cancer, diabetes and Alzheimer’s disease. The tests can enable you and your physician to come up with a personalized health plan to prevent the conditions, delay them or detect them early.

Read More

Navigenics is pleased to announce the acquisition of a clinical testing facility for our genetic testing services. I’d like to share the details about this exciting opportunity, as described in a news release issued today:

Navigenics, a leading personal genomics testing company, announced today the acquisition of the Affymetrix Clinical Services Laboratory, a CLIA-certified testing facility that provides molecular genome scanning using the Affymetrix GeneChip® microarray platform. With the purchase of this testing facility, Navigenics can now offer fully integrated genome screening and analysis under one roof.

Read More